BeOne Medicines (ONC) Debt Ratio (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Debt Ratio data on file, last reported at 0.11 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 29.09% year-over-year to 0.11 in Q1 2026; TTM through Mar 2026 was 0.11, a 29.09% decrease from a year earlier, with the FY2025 full-year figure at 0.12, down 27.61% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.11, down from 0.12 in the prior quarter.
• Over the last five years, Debt Ratio for ONC reached as high as 0.18 in Q2 2024 and fell as low as 0.03 in Q3 2025.
• Historically, Debt Ratio has averaged 0.12 across 5 years, with a median of 0.11 in 2026.
• Across the five-year window, Debt Ratio jumped 222.8% in 2023 and tumbled 86.06% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.05 in 2022, then soared by 222.8% to 0.15 in 2023, then advanced by 12.66% to 0.17 in 2024, then retreated by 27.61% to 0.12 in 2025, then slipped by 9.92% to 0.11 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.11 in Q1 2026, 0.12 in Q4 2025, and 0.03 in Q3 2025.